Literature DB >> 20890583

Diagnostic and prognostic role of procalcitonin in infections.

Maria Hatzistilianou1.   

Abstract

Despite several consensus conferences, the criteria for the definition of sepsis are still considered too sensitive and insufficiently specific. The traditional clinical signs of infection and routine laboratory tests used to diagnose bacterial infection and sepsis lack diagnostic accuracy and can be misleading, particularly in patients with immunodeficiencies. The problems with sepsis definitions and diagnoses are indications of the need to focus on biochemical mediators capable not only of distinguishing the inflammatory response to infection from other types of inflammation, but also of indicating the severity and prognosis of the disease. Thus, physicians need an early and rapid marker for detecting bacterial infection and distinguishing it from viral infection. Several studies revealed that elevated procalcitonin (PCT) levels in human blood could be detected in cases of sepsis and bacterial infection. PCT is a protein that can act as a hormone and a cytokine. It can be produced by several cell types and many organs in response to proinflammatory stimuli, particularly bacterial infection. It provides a rapid diagnostic test, available at the patient's bedside, and its half-life is suitable for daily monitoring of the disease progress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890583      PMCID: PMC5763968          DOI: 10.1100/tsw.2010.181

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  12 in total

1.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

2.  Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia.

Authors:  T Mölkänen; E Ruotsalainen; C W Thorball; A Järvinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

Review 3.  Biomarkers in Acute Heart Failure: Diagnosis, Prognosis, and Treatment.

Authors:  Nicholas Wettersten
Journal:  Int J Heart Fail       Date:  2021-02-15

4.  Novel biomarkers to detect infection in revision hip and knee arthroplasties.

Authors:  Mathias Glehr; Joerg Friesenbichler; Günter Hofmann; Gerwin Alexander Bernhardt; Maximilian Zacherl; Alexander Avian; Reinhard Windhager; Andreas Leithner
Journal:  Clin Orthop Relat Res       Date:  2013-04-23       Impact factor: 4.176

5.  Biomarkers for the diagnosis of bacterial infections: in pursuit of the 'Holy Grail'.

Authors:  Alladi Mohan; J Harikrishna
Journal:  Indian J Med Res       Date:  2015-03       Impact factor: 2.375

6.  The diagnostic values of C-reactive protein and procalcitonin in identifying systemic lupus erythematosus infection and disease activity.

Authors:  Jing Wang; Rong Niu; Lijuan Jiang; Yuetao Wang; Xiaonan Shao; Min Wu; Yingchun Ma
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  Serum procalcitonin and C-reactive protein in the evaluation of bacterial infection in generalized pustular psoriasis.

Authors:  Siyu Wang; Zhen Xie; Zhu Shen
Journal:  An Bras Dermatol       Date:  2019-09-30       Impact factor: 1.896

8.  Procalcitonin and Other Biomarkers of Sepsis in Newborns in the Intensive Care Unit.

Authors:  Daniela Bartolovic; Svetlana Ignjatovic; Sanja Stankovic; Singh Nada Majkić
Journal:  EJIFCC       Date:  2011-03-14

9.  Serum procalcitonin as a biomarker of bloodstream infection & focal bacterial infection in febrile patients.

Authors:  Janjam Harikrishna; Alladi Mohan; D P Kalyana Chakravarthi; Abhijit Chaudhury; B Siddhartha Kumar; K V S Sarma
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

10.  Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.

Authors:  Mina Yang; Seung Jun Choi; Jaewoong Lee; Dong Gun Lee; Yoon-Joo Kim; Yeon-Joon Park; Eun-Jee Oh
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.